Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) FCF Margin (2020 - 2025)

Pulse Biosciences (PLSE) has 4 years of FCF Margin data on record, last reported at 5628.79% in Q4 2025.

  • For Q4 2025, FCF Margin changed N/A year-over-year to 5628.79%; the TTM value through Dec 2025 reached 15553.43%, changed N/A, while the annual FY2025 figure was 15553.43%, N/A changed from the prior year.
  • FCF Margin reached 5628.79% in Q4 2025 per PLSE's latest filing, up from 15233.72% in the prior quarter.
  • Across five years, FCF Margin topped out at 88955.56% in Q4 2022 and bottomed at 15233.72% in Q3 2025.
  • Average FCF Margin over 3 years is 7697.75%, with a median of 2353.14% recorded in 2021.
  • Peak YoY movement for FCF Margin: soared 15738009bps in 2021, then plummeted -1387149bps in 2022.
  • A 3-year view of FCF Margin shows it stood at 1519.91% in 2021, then surged by 5953bps to 88955.56% in 2022, then tumbled by -106bps to 5628.79% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 5628.79% in Q4 2025, 15233.72% in Q3 2025, and 88955.56% in Q4 2022.